227 related articles for article (PubMed ID: 34703209)
1. Triptolide is a Promising Therapeutic Approach in Treating Thyroid Cancer Based on in silico and in vitro Experiment.
Wang F; An SJ; Yin Y; Li JJ; Sun CH; Lan J; Zhao WJ; Li CQ
Drug Des Devel Ther; 2021; 15():4275-4287. PubMed ID: 34703209
[TBL] [Abstract][Full Text] [Related]
2. Potential Mechanisms of Triptolide against Diabetic Cardiomyopathy Based on Network Pharmacology Analysis and Molecular Docking.
Zhu N; Huang B; Zhu L; Wang Y
J Diabetes Res; 2021; 2021():9944589. PubMed ID: 34926700
[TBL] [Abstract][Full Text] [Related]
3. The Anti-Tumor Mechanism and Target of Triptolide Based on Network Pharmacology and Molecular Docking.
Zou T; Huang Y; Hu Y; Wu M; Zhao Y; Du F; Li M; Wu X; Ji H; Kaboli PJ; Wang S; Xiao Z; Wu Z
Recent Pat Anticancer Drug Discov; 2021; 16(3):426-435. PubMed ID: 33573560
[TBL] [Abstract][Full Text] [Related]
4. Triptolide inhibits tumor promoter-induced uPAR expression via blocking NF-kappaB signaling in human gastric AGS cells.
Chang HJ; Kim MH; Baek MK; Park JS; Chung IJ; Shin BA; Ahn BW; Jung YD
Anticancer Res; 2007; 27(5A):3411-7. PubMed ID: 17970088
[TBL] [Abstract][Full Text] [Related]
5. Synergistic cytotoxicity of BIIB021 with triptolide through suppression of PI3K/Akt/mTOR and NF-κB signal pathways in thyroid carcinoma cells.
Kim SH; Kang JG; Kim CS; Ihm SH; Choi MG; Yoo HJ; Lee SJ
Biomed Pharmacother; 2016 Oct; 83():22-32. PubMed ID: 27470546
[TBL] [Abstract][Full Text] [Related]
6. Triptolide induces apoptosis in human anaplastic thyroid carcinoma cells by a p53-independent but NF-kappaB-related mechanism.
Zhu W; Hu H; Qiu P; Yan G
Oncol Rep; 2009 Dec; 22(6):1397-401. PubMed ID: 19885592
[TBL] [Abstract][Full Text] [Related]
7. Triptolide suppresses growth and hormone secretion in murine pituitary corticotroph tumor cells via NF-kappaB signaling pathway.
Li R; Zhang Z; Wang J; Huang Y; Sun W; Xie R; Hu F; Lei T
Biomed Pharmacother; 2017 Nov; 95():771-779. PubMed ID: 28892788
[TBL] [Abstract][Full Text] [Related]
8. ITRAQ-Based Proteomics Analysis of Triptolide On Human A549 Lung Adenocarcinoma Cells.
Li F; Zhao D; Yang S; Wang J; Liu Q; Jin X; Wang W
Cell Physiol Biochem; 2018; 45(3):917-934. PubMed ID: 29428961
[TBL] [Abstract][Full Text] [Related]
9. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells.
Jiang XH; Wong BC; Lin MC; Zhu GH; Kung HF; Jiang SH; Yang D; Lam SK
Oncogene; 2001 Nov; 20(55):8009-18. PubMed ID: 11753684
[TBL] [Abstract][Full Text] [Related]
10. The mechanism of triptolide in the treatment of connective tissue disease-related interstitial lung disease based on network pharmacology and molecular docking.
Zhu W; Li Y; Zhao J; Wang Y; Li Y; Wang Y
Ann Med; 2022 Dec; 54(1):541-552. PubMed ID: 35132912
[TBL] [Abstract][Full Text] [Related]
11. Network pharmacology of triptolide in cancer cells: implications for transcription factor binding.
Seo EJ; Dawood M; Hult AK; Olsson ML; Efferth T
Invest New Drugs; 2021 Dec; 39(6):1523-1537. PubMed ID: 34213719
[TBL] [Abstract][Full Text] [Related]
12. Suppression of the migration and invasion is mediated by triptolide in B16F10 mouse melanoma cells through the NF-kappaB-dependent pathway.
Jao HY; Yu FS; Yu CS; Chang SJ; Liu KC; Liao CL; Ji BC; Bau DT; Chung JG
Environ Toxicol; 2016 Dec; 31(12):1974-1984. PubMed ID: 26420756
[TBL] [Abstract][Full Text] [Related]
13. Prediction of triptolide targets in rheumatoid arthritis using network pharmacology and molecular docking.
Song X; Zhang Y; Dai E; Wang L; Du H
Int Immunopharmacol; 2020 Mar; 80():106179. PubMed ID: 31972422
[TBL] [Abstract][Full Text] [Related]
14. Anti-Inflammatory and Neuroprotective Effects of Triptolide via the NF-κB Signaling Pathway in a Rat MCAO Model.
Bai S; Hu Z; Yang Y; Yin Y; Li W; Wu L; Fang M
Anat Rec (Hoboken); 2016 Feb; 299(2):256-66. PubMed ID: 26575184
[TBL] [Abstract][Full Text] [Related]
15. Triptolide inhibits proliferation and induces apoptosis of human melanoma A375 cells.
Tao Y; Zhang ML; Ma PC; Sun JF; Zhou WQ; Cao YP; Li LJ
Asian Pac J Cancer Prev; 2012; 13(4):1611-5. PubMed ID: 22799376
[TBL] [Abstract][Full Text] [Related]
16. Triptolide Inhibits Invasion and Tumorigenesis of Hepatocellular Carcinoma MHCC-97H Cells Through NF-κB Signaling.
Wang H; Ma D; Wang C; Zhao S; Liu C
Med Sci Monit; 2016 May; 22():1827-36. PubMed ID: 27239780
[TBL] [Abstract][Full Text] [Related]
17. Synergism of cytotoxicity effects of triptolide and artesunate combination treatment in pancreatic cancer cell lines.
Liu Y; Cui YF
Asian Pac J Cancer Prev; 2013; 14(9):5243-8. PubMed ID: 24175808
[TBL] [Abstract][Full Text] [Related]
18. Selective tumor cell killing by triptolide in p53 wild-type and p53 mutant ovarian carcinomas.
Wu J; Li QQ; Zhou H; Lu Y; Li JM; Ma Y; Wang L; Fu T; Gong X; Weintraub M; Wu S; Ding H
Med Oncol; 2014 Jul; 31(7):14. PubMed ID: 24880464
[TBL] [Abstract][Full Text] [Related]
19. Triptolide inhibits Epstein-Barr nuclear antigen 1 expression by increasing sensitivity of mitochondria apoptosis of nasopharyngeal carcinoma cells.
Zhou H; Liu Y; Wang C; Liu L; Wang H; Zhang Y; Long C; Sun X
J Exp Clin Cancer Res; 2018 Aug; 37(1):192. PubMed ID: 30111354
[TBL] [Abstract][Full Text] [Related]
20. Triptolide ameliorates fine particulate matter-induced podocytes injury via regulating NF-κB signaling pathway.
Wan Q; Liu Z; Yang M; Deng P; Tang N; Liu Y
BMC Mol Cell Biol; 2020 Feb; 21(1):4. PubMed ID: 32013860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
